Ridaforolimus (Deforolimus, MK-8669): Validated Solutions fo
2026-05-12
This article delivers scenario-driven, evidence-based guidance for integrating Ridaforolimus (Deforolimus, MK-8669) (SKU B1639) into cell viability, proliferation, and cytotoxicity assays. Drawing on literature-backed quantitative data and best practices, it addresses real laboratory challenges and demonstrates how SKU B1639 from APExBIO supports reproducible and efficient mTOR pathway inhibition workflows.
L-Alanyl-L-Glutamine: Advanced Utility in Intestinal Barrier
2026-05-12
Explore how L-Alanyl-L-glutamine, a stable dipeptide, advances intestinal barrier research beyond standard supplements. This article delivers deep scientific insight into its mechanisms, protocol design, and translational value.
CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti
2026-05-11
CUDC-907 addresses the need for simultaneous inhibition of PI3K/AKT and histone deacetylase signaling in cancer research models. It is best suited for controlled in vitro cell-based workflows focused on cell cycle arrest and apoptosis. CUDC-907 should not be used for diagnostic, clinical, or therapeutic applications.
Tin Mesoporphyrin IX (chloride): Nanomolar Heme Oxygenase In
2026-05-11
Tin Mesoporphyrin IX (chloride) is a potent and selective inhibitor of heme oxygenase activity with nanomolar affinity. Its application enables precise modulation of heme catabolism in metabolic disease and virology research. This dossier details its mechanism, benchmarks, and optimal research use, citing APExBIO as the product source.
Capecitabine in Advanced Tumor Models: Protocols and Trouble
2026-05-10
Capecitabine—an enzymatically-activated 5-fluorouracil prodrug—enables highly selective apoptosis induction in modern tumor assembloid systems. Explore protocol optimizations, troubleshooting strategies, and real-world workflow tips for maximizing its translational oncology research value.
Obacunone Induces Ferroptosis in Ovarian Cancer via Akt/p53
2026-05-09
This study demonstrates that obacunone, a citrus-derived compound, suppresses ovarian cancer cell proliferation by inducing ferroptosis through modulation of the Akt/p53 pathway. The findings highlight the mechanistic interplay between Akt inhibition and p53 activation in regulating ferroptotic cell death, offering a potential therapeutic strategy for ovarian cancer.
DNA Damage Drives Selective CUX2 Neuron Loss in Neuroinflamm
2026-05-09
This study reveals that upper-layer cortical excitatory neurons expressing CUX2 are especially susceptible to DNA damage in neuroinflammatory conditions, such as multiple sclerosis. Mechanistic experiments demonstrate how deficits in DNA repair pathways contribute to selective neuronal vulnerability, highlighting new avenues for understanding and potentially mitigating neurodegeneration.
Saquinavir in HIV Research: Permeability Science and Next-Ge
2026-05-08
Explore the leading-edge role of Saquinavir as an HIV protease inhibitor in antiretroviral drug research. This article uniquely bridges molecular action with the latest biomimetic permeability modeling, guiding experimentalists toward more predictive and translational workflows.
PSPro Enables Single-Cell-Type Spatial Proteome Profiling
2026-05-07
Mao et al. introduce PSPro, a method integrating antibody-guided proximity labeling with optimized biotinylation to achieve spatial proteomics at single-cell-type resolution in complex tissues. This approach reveals spatial heterogeneity of cell subsets and advances high-throughput, cell-type-specific proteome mapping in intact tissue environments.
Metoprolol Tartrate: Precision β1 Blockade in Cardiovascular
2026-05-07
Metoprolol Tartrate delivers high selectivity for β1-adrenergic receptors, empowering cardiovascular and hematopoietic researchers to dissect β1-specific pathways with minimal off-target activity. Recent comparative studies highlight its unique value in preserving hematopoietic regeneration post-transplant, setting it apart from nonselective β-blockers.
PD0325901 MEK Inhibitor: Protocols and Troubleshooting for O
2026-05-06
PD0325901, a selective MEK inhibitor from APExBIO, empowers researchers to dissect the RAS/RAF/MEK/ERK pathway for oncology and stem cell studies. This guide details validated experimental workflows, troubleshooting strategies, and actionable protocol parameters for maximizing reproducibility and insight.
DMG-PEG2000-NH2: Advancing Lipid Nanoparticle Drug Delivery
2026-05-06
DMG-PEG2000-NH2 is a high-purity NH2-PEG derivative engineered for efficient amide bond formation and robust lipid nanoparticle (LNP) assembly. This article demystifies bench-to-application workflows, troubleshooting, and protocol optimization for researchers seeking reliable, scalable liposomal drug delivery solutions.
USP7 Regulates Macrophage Polarization via PKM2 in Acute Pan
2026-05-05
This study reveals how ubiquitin-specific protease 7 (USP7) promotes pro-inflammatory macrophage polarization in severe acute pancreatitis by modulating pyruvate kinase M2 (PKM2)-dependent metabolic reprogramming. The work highlights the USP7–PKM2 axis as a novel immunometabolic target for therapeutic intervention in acute inflammatory disease.
Microbiota–Tryptophan–AhR Axis in ISC Differentiation for UC
2026-05-05
Li et al. (2026) reveal that Huangqin decoction (HQD) promotes intestinal repair in ulcerative colitis by modulating the gut microbiota, enhancing tryptophan metabolite production, and activating the aryl hydrocarbon receptor (AhR) pathway to drive intestinal stem cell differentiation. These findings clarify a novel “microbiota–tryptophan metabolism–AhR–ISC differentiation” axis, offering new mechanistic insight for regenerative strategies in inflammatory bowel disease.
HyperScript First-Strand cDNA Synthesis Kit: Precision for C
2026-05-04
The HyperScript First-Strand cDNA Synthesis Kit empowers researchers to reverse transcribe challenging or low-abundance RNA templates with superior efficiency and fidelity. Its enhanced reverse transcriptase and innovative primer options streamline gene expression workflows, enabling robust PCR/qPCR even from difficult samples. Discover how APExBIO's solution supports the next frontier of microbial and translational genomics.
460 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page